Increasing interest in designing chemotherapy suitable for use in the elderly and in poor
performance status (PS) patients has led to clinical trials in advanced non-small cell lung cancer …

… comorbidities and performance status, on short-term outcomes in the very elderly is largely
… in critically ill patients ≥80 years old, emphasizing performance status and comorbidities, …

… patients. However, most clinical trials on ICIs conducted so far have either excluded patients
with poor performance status (… only a minor proportion of elderly patients despite the lack of …

… the instance of comorbidity and performance status, its careful … younger patients with
poor/borderline PS and elderly patients … that of age, performance status and comorbidity burden. …

… No significant differences in social environment, marital status, or education were observed.
… , performance status, and medication taken, elderly neoplastic patients presented in poorer …

… Data from the current study suggest that assessing performance status may be useful in
counseling patients for surgical treatments as well. In our elderly population a KPS of 90 or 100 …

… performance status evaluated by the ECOG score in predicting 30-day mortality in patients
… This data seems of relevance, since in elderly patients, the performance status is a variable …

… NSCLC) is a disease of the elderly. Seeking a tolerable but effective … elderly and/or poor
performance status patients with locally advanced NSCLC. Patients and methods: Older patients …

Purpose The management of glioblastoma multiforme (GBM) in elderly patients with poor
performance status is not well established. A trial evaluating the efficacy and safety of …

Background: We conducted a multicenter randomized phase II trial to evaluate two schedules
of single-agent docetaxel in the first-line treatment of elderly and performance status (PS) …